ALX Oncology Inc.
(ALXO)
undefined
undefined%
At close: undefined
1.49
2.76%
After-hours Dec 13, 2024, 07:53 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -160.81M | -123.48M | -83.46M | -45.74M | -19.24M | -13.73M |
| Depreciation & Amortization | 836.00K | 342.00K | 51.00K | 202.00K | 429.00K | 431.00K |
| Stock-Based Compensation | 26.27M | 23.84M | 13.91M | 5.44M | 297.00K | 269.00K |
| Other Working Capital | 7.84M | 5.34M | -7.32M | 3.99M | 1.28M | 110.00K |
| Other Non-Cash Items | -4.96M | 228.00K | 5.42M | 295.00K | 11.00K | 2.33M |
| Deferred Income Tax | - | - | - | 1.27M | - | - |
| Change in Working Capital | 8.30M | 9.85M | -4.03M | 247.00K | 4.26M | -159.00K |
| Operating Cash Flow | -130.36M | -89.22M | -68.10M | -38.29M | -14.25M | -13.19M |
| Capital Expenditures | -1.27M | -1.43M | -4.92M | -31.00K | -353.00K | -653.00K |
| Acquisitions | - | 233.99K | - | 641.00K | - | - |
| Purchase of Investments | -246.63M | -376.79M | - | - | - | - |
| Sales Maturities Of Investments | 292.56M | 142.80M | - | - | - | - |
| Other Investing Acitivies | - | -233.99K | -4.26M | 641.00K | - | - |
| Investing Cash Flow | 44.66M | -235.42M | -4.92M | 610.00K | -353.00K | -653.00K |
| Debt Repayment | -388.00K | 9.61M | -281.00K | -6.51M | 5.92M | - |
| Common Stock Repurchased | - | 336.00K | 202.00K | - | - | -6.00K |
| Dividend Paid | - | - | - | -3.00K | - | - |
| Other Financial Acitivies | 792.00K | 248.00K | 2.75M | 104.68M | 9.44M | 7.00K |
| Financial Cash Flow | 59.29M | 9.86M | 2.47M | 462.88M | 15.36M | 1K |
| Net Cash Flow | -26.42M | -314.78M | -70.55M | 425.20M | 755.00K | -13.84M |
| Free Cash Flow | -131.64M | -90.65M | -73.02M | -38.32M | -14.60M | -13.84M |